We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-1.37%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.2B
AUM Growth
+$2.05B
Cap. Flow
+$2.63B
Cap. Flow %
18.56%
Top 10 Hldgs %
24.41%
Holding
915
New
139
Increased
425
Reduced
186
Closed
46

Sector Composition

Rank Sector Weight
1 Healthcare 31.77%
2 Technology 24.47%
3 Financials 9.64%
4 Consumer Discretionary 7.95%
5 Industrials 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COP icon
126
ConocoPhillips
COP
$139B
$25.7M 0.18%
251,309
-62,300
-20% -$6.21M
TJX icon
127
TJX Companies
TJX
$176B
$25.3M 0.18%
407,530
+259,694
+176% +$16.3M
XYL icon
128
Xylem
XYL
$29.7B
$25M 0.18%
286,627
-9,064
-3% -$824K
VRNS icon
129
Varonis Systems
VRNS
$5.31B
$25M 0.18%
942,857
+267,238
+40% +$7.62M
GBT
130
DELISTED
Global Blood Therapeutics, Inc.
GBT
$24.6M 0.17%
360,956
-418,735
-54% -$23.1M
HAS icon
131
Hasbro
HAS
$13.4B
$24.5M 0.17%
363,825
+293,682
+419% +$23.2M
HUM icon
132
Humana
HUM
$46.2B
$24.5M 0.17%
50,502
+15,253
+43% +$7.42M
CYTK icon
133
Cytokinetics
CYTK
$10.8B
$24.4M 0.17%
503,240
-17,236
-3% -$830K
OLED icon
134
Universal Display
OLED
$3.85B
$24.3M 0.17%
257,439
+4,003
+2% +$443K
CHD icon
135
Church & Dwight Co
CHD
$23.8B
$24.3M 0.17%
339,514
+142,189
+72% +$12.3M
BRKR icon
136
Bruker
BRKR
$9.49B
$23.8M 0.17%
448,186
+35,000
+8% +$2.09M
GWW icon
137
W.W. Grainger
GWW
$66.1B
$23.7M 0.17%
48,388
+38,461
+387% +$20.2M
CSX icon
138
CSX Corp
CSX
$95.4B
$23.7M 0.17%
887,886
+724,634
+444% +$22.5M
APLS
139
DELISTED
Apellis Pharmaceuticals
APLS
$23.5M 0.17%
343,507
-271,950
-44% -$16.1M
GIS icon
140
General Mills
GIS
$20.1B
$23.4M 0.17%
305,726
+233,264
+322% +$17.8M
EA icon
141
Electronic Arts
EA
$52.4B
$23.3M 0.16%
201,153
+31,705
+19% +$4.01M
ICE icon
142
Intercontinental Exchange
ICE
$86.3B
$23.1M 0.16%
255,912
+184,221
+257% +$18.5M
ARVN icon
143
Arvinas
ARVN
$521M
$23.1M 0.16%
519,292
+22,345
+4% +$1.08M
BRK.B icon
144
Berkshire Hathaway Class B
BRK.B
$1.1T
$22.7M 0.16%
85,059
-7,165
-8% -$2.04M
INSM icon
145
Insmed
INSM
$22.7B
$22.7M 0.16%
1,052,200
-830,248
-44% -$19.9M
ES icon
146
Eversource Energy
ES
$28.6B
$22.6M 0.16%
290,130
+246,338
+563% +$21.7M
DFS
147
DELISTED
Discover Financial Services
DFS
$22M 0.16%
242,424
+29,705
+14% +$3.01M
CHGG icon
148
Chegg
CHGG
$114M
$22M 0.16%
+1,044,457
New +$21.6M
HCA icon
149
HCA Healthcare
HCA
$89.9B
$21.9M 0.15%
118,944
-29,618
-20% -$5.9M
TRI icon
150
Thomson Reuters
TRI
$45.4B
$21.9M 0.15%
200,986
+100,160
+99% +$11.6M

Similar funds

Candriam SCA's Q3 2022 Portfolio in Review

As of Q3 2022, Candriam SCA held 915 positions worth $14.2B, up 17% from $12.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA deployed $2.63B of net new capital in Q3 2022, opening 139 new positions and adding to 425 existing holdings. Its largest new stake was Veru: 378,115 shares worth $43.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 34% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Sociedad Química y Minera de Chile, an estimated $60.4M trimmed.

  • Candriam SCA's largest Q3 2022 buy was Veru: 378,115 shares worth $43.6M.
  • Candriam SCA added most to Apple in Q3 2022, an estimated $226M increase.
  • Candriam SCA's biggest Q3 2022 reduction was Sociedad Química y Minera de Chile, cutting an estimated $60.4M.
  • Candriam SCA fully exited Turning Point Therapeutics, Inc. Common Stock in Q3 2022, selling an estimated $36.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.2B portfolio in Q3 2022.
  • Candriam SCA opened 139 new positions and closed 46 in Q3 2022.
  • Candriam SCA's portfolio value rose 17% quarter-over-quarter to $14.2B.

Based on Candriam SCA's 13F filing for Q3 2022, filed 10 Nov 2022.